The insensitivity of the clinical scales usually performed in MS patients led to measure the quality of life (QoL). QoL includes several important domains of health which are regarded by patients as being more important determinants of their overall health states. Some aspects of QoL of MS patients (early collapse in the disease, impact of interferons therapy) suggested that its measurement is relevant in assessing the effect of treatment and progression of the disease.